WOCKPHARMA2020-04-012020-06-30in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2020-04-012020-06-30in-bse-fin:OneOperatingExpenses02Member WOCKPHARMA2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member WOCKPHARMA2020-04-012020-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2020-04-01 2021-03-31 2020-08-19 INR Crores First quarter Single segment Pharmaceuticals 2020-04-01 2020-06-30 Unaudited Standalone 1775800000.00 97400000.00 1873200000.00 106800000.00 504300000.00 148500000.00 820800000.00 586100000.00 460800000.00 1150900000.00 3778200000.00 -1905000000.00 -1424800000.00 -3329800000.00 -698900000.00 -441500000.00 -1140400000.00 0.00 -2189400000.00 14841900000.00 4988600000.00 9853300000.00 0.00 7663900000.00 13100000.00 7677000000.00 0.00 0.00 553700000.00 5 -19.77 -19.77 88.98 88.64 69.21 68.87 Notes To Standalone Results :- n n1. For Notes to Standalone Results please refer the notes from the Statement of Standalone Unaudited Results for the quarter ended June 30, 2020 as attached which is submitted under Outcome of Board Meeting today. n n2. Income represents Income from continuing operations, Expenses represents Expenses from continuing operations, Tax expense represents Tax expense of continuing operations, Exceptional items represents Exceptional items-credit/(charge) from Continuing Operations, Total profit before exceptional items and tax represents Profit / (Loss) before exceptional items and tax from Continuing Operations, Total profit before tax represents Profit / (Loss) after exceptional items and before tax from Continuing Operations and Profit / (Loss) from discontinued operations before tax represents Profit / (Loss) after exceptional items and before tax from Discontinued Operations. n n3. Profit / (Loss) from Discontinued Operations before tax includes Profit before exceptional items and tax from Discontinued Operations Rs. 13.87 crore and Exceptional items- credit/(charge)- Discontinued Operations Rs. 1470.32 crore n n4. Tax expense represents Tax expense of continuing operations which includes Current tax - (credit) / charge of Rs.(69.89) crore and Deferred tax- (credit) / charge of Rs. (44.15) crore n n5. Tax expense of discontinued operations includes Current tax - charge/(credit) of Rs. 311.49 crore and Deferred tax - charge/(credit) of Rs. 187.37 crore n n6. Diluted EPS from continuing and discontinued operations for the Quarter ended June 30, 2020 is Rs.68.94 instead of Rs. 68.87 calculated as per table. n n7. EPS for the Quarter ended June 30, 2020 from Continuing operations, Discontinued operations and Continuing and Discontinued operations is not annualised. n nOCI Segment: n8. Income tax relating items that will not be classified to Profit or loss includes income tax relating to items that will not be reclassified to Profit or loss from Continuing operations and Discontinued operations. Exchange fluctuation loss / (gain), net 33000000.00 Other expenses 1117900000.00